MyFinsight
Home
About
Contact
Back
Income Statement
RIGEL PHARMACEUTICALS INC (RIGL)
source: myfinsight.com
Download
Download image
Release Of Cost Share
Liability
$39,981K
Royalty Delivery Of Drug
Supplies And Others
$2,756K
Gross Product
$79,692K
Revenue-Contract Revenues From
Collaborations
$42,737K
Revenue-Product
$58,948K
Discounts And Allowances
-$20,744K
Total revenues
$101,685K
(176.01%↑ Y/Y)
Interest income
$753K
(36.41%↑ Y/Y)
Income (loss) from
operations
$61,103K
(13569.57%↑ Y/Y)
Total costs and
expenses
$40,582K
(11.51%↑ Y/Y)
Income (loss) before
income taxes
$59,982K
Interest expense
$1,874K
(-7.64%↓ Y/Y)
Cost of product sales
$4,504K
(60.46%↑ Y/Y)
Research and development
$6,821K
(23.12%↑ Y/Y)
Selling, general and
administrative
$29,257K
(4.31%↑ Y/Y)
Net income (loss)
$59,613K
(5887.67%↑ Y/Y)
Provision for income taxes
$369K
Back